Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors

被引：37
|
作者：
Zettl, Heiko [1 ]
Schubert-Zsilavecz, Manfred [1 ]
Steinhilber, Dieter [1 ]
机构：
[1] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany
来源：
CHEMMEDCHEM | 2010年 / 5卷 / 02期
关键词：
DPP-4; inhibitors; drug discovery; incretin mimetics; medicinal chemistry; DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; TYPE-2; DIABETES-MELLITUS; ANTIHYPERGLYCEMIC PROPERTIES; HEALTHY-VOLUNTEERS; RECEPTOR AGONISTS; CRYSTAL-STRUCTURE; POTENT; PHARMACOKINETICS; PHARMACODYNAMICS;
D O I：
10.1002/cmdc.200900448
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：179 / 185
页数：7
相关论文
共 50 条
  • [41] Xanthine mimetics as novel DPP4 inhibitors
    Kurukulasuriya, R
    Rohde, JJ
    Szczepankiewicz, BG
    Basha, FZ
    Longenecker, K
    Ballaron, S
    Link, JT
    Von Geldern, T
    Lubben, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2675 - U2675
  • [42] Incretin-based antidiabetics: GLP-1 mimetics and DPP-IV inhibitors
    Gallwitz, B.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : 234 - +
  • [43] Plasma DPP-4 Inhibition by Sitagliptin and Other DPP-4 Inhibitors Correlates with and Predicts Glucose Lowering Efficacy
    Roy, Ranabir Sinha
    Wu, Joseph
    Eiermann, George
    Lyons, Kathryn
    He, Huaibing
    Weber, Ann
    Thornberry, Nancy
    DIABETES, 2009, 58 : A612 - A612
  • [44] Evidence for antifibrotic incretin-independent effects of the DPP-4 inhibitor linagliptin
    Zeisberg, Michael
    Zeisberg, Elisabeth M.
    KIDNEY INTERNATIONAL, 2015, 88 (03) : 429 - 431
  • [45] Incretin mimetics and DPP-IV inhibitors: New paradigms for the treatment of type 2 diabetes
    Hinnen, Deborah
    Nielsen, Loretta L.
    Waninger, Amy
    Kushner, Pamela
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2006, 19 (06) : 612 - 620
  • [46] DPP-4 inhibitors and risk of heart failure EXAMINEd
    Standl, Eberhard
    Schnell, Oliver
    LANCET, 2015, 385 (9982): : 2022 - 2024
  • [47] Major adverse cardiac events with DPP-4 inhibitors
    Reactions Weekly, 2018, 1699 (1) : 7 - 7
  • [48] In Silico Study of Flavonoids as DPP-4 and α-glucosidase Inhibitors
    Kaur, Jasmin
    Singla, Ramit
    Jaitak, Vikas
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (06) : 634 - 642
  • [49] Increased risk of bullous pemphigoid with DPP-4 inhibitors
    Reactions Weekly, 2018, 1717 (1) : 6 - 6
  • [50] Recent progress in natural products as DPP-4 inhibitors
    Gao, Yuanyuan
    Zhang, Yong
    Zhu, Jianming
    Li, Bo
    Li, Zhao
    Zhu, Weiliang
    Shi, Jiye
    Jia, Qi
    Li, Yiming
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (08) : 1079 - 1089
12345